אלצהיימר ודמנציות אחרות | רחל ברנבאום עורכת

אלצהיימר ודמנציות אחרות 23 Rosler, M., Anand, R., Cicin-Sain, A. et al. (1999). Efficacy and safety of Rivastigmine in patients with Alzheimer’s disease: International randomized controlled trial. British Medical Journal , 318: 633-638. Sclan, S.G. & Reisberg, B. (1992). Functional assessment staging (FAST) in Alzheimer’s disease: Reliability, validity and ordinality. International Psychogeriatrics , 4 (Suppl 1): 55-69. Stewart, R. (2002). Vascular dementia: A diagnosis running out of time. British Journal of Psychiatry , 180: 152-156. Vennerica, A. et al. (2002). Clusters of increment in regional cerebral blood flow observed in patients at 3 and 6 months that responded to Rivastigmine [Exelon]. Neuroreport , 13:83-7.